Hjerneskademarkøren S100B kan mindske brugen af computertomografi ved lette hovedtraumer--sekundaerpublikation

Jacob Bertram Springborg; Johan Undén; Tor Ingebrigtsen; Bertil Romner

Hjerneskademarkøren S100B kan mindske brugen af computertomografi ved lette hovedtraumer--sekundaerpublikation

Jacob Bertram Springborg
, Johan Undén
, Tor Ingebrigtsen
, Bertil Romner

Afdeling for Hjerne- og Nervekirurgi NEU

14 Citationer (Scopus)

Abstract

The risk of acute intracranial complications after minor head injury (MHI) is low. Despite this, computed tomography (CT) is generally recommended with clinical observation as a secondary option. Both options have disadvantages. Clinical studies have shown the potential advantages of using the biomarker S100B. The specificity of S100B is low, but a high sensitivity for brain damage results in a clinically useful, high negative predictive value (NPV). Integration of S100B into existing management routines can reduce the need for CT scans or admission by over 30%.

Bidragets oversatte titel	Brain injury marker S100B can reduce the use of computer tomography in minor head injuries--secondary publication
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	171
Udgave nummer	12
Sider (fra-til)	978-81
Antal sider	4
ISSN	0041-5782
Status	Udgivet - 16 mar. 2009

Emneord

Adult
Biomarkers/blood
Child
Cost Savings
Craniocerebral Trauma/blood
Humans
Nerve Growth Factors/blood
Practice Guidelines as Topic
Predictive Value of Tests
S100 Calcium Binding Protein beta Subunit
S100 Proteins/blood
Sensitivity and Specificity
Tomography, X-Ray Computed/economics

Citationsformater

@article{a6c5550d95d6430cafd19782ff27c192,

title = "Hjerneskademark{\o}ren S100B kan mindske brugen af computertomografi ved lette hovedtraumer--sekundaerpublikation",

abstract = "The risk of acute intracranial complications after minor head injury (MHI) is low. Despite this, computed tomography (CT) is generally recommended with clinical observation as a secondary option. Both options have disadvantages. Clinical studies have shown the potential advantages of using the biomarker S100B. The specificity of S100B is low, but a high sensitivity for brain damage results in a clinically useful, high negative predictive value (NPV). Integration of S100B into existing management routines can reduce the need for CT scans or admission by over 30\%.",

keywords = "Adult, Biomarkers/blood, Child, Cost Savings, Craniocerebral Trauma/blood, Humans, Nerve Growth Factors/blood, Practice Guidelines as Topic, Predictive Value of Tests, S100 Calcium Binding Protein beta Subunit, S100 Proteins/blood, Sensitivity and Specificity, Tomography, X-Ray Computed/economics",

author = "Springborg, \{Jacob Bertram\} and Johan Und{\'e}n and Tor Ingebrigtsen and Bertil Romner",

year = "2009",

month = mar,

day = "16",

language = "Dansk",

volume = "171",

pages = "978--81",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske L{\ae}geforening",

number = "12",

}

TY - JOUR

T1 - Hjerneskademarkøren S100B kan mindske brugen af computertomografi ved lette hovedtraumer--sekundaerpublikation

AU - Springborg, Jacob Bertram

AU - Undén, Johan

AU - Ingebrigtsen, Tor

AU - Romner, Bertil

PY - 2009/3/16

Y1 - 2009/3/16

N2 - The risk of acute intracranial complications after minor head injury (MHI) is low. Despite this, computed tomography (CT) is generally recommended with clinical observation as a secondary option. Both options have disadvantages. Clinical studies have shown the potential advantages of using the biomarker S100B. The specificity of S100B is low, but a high sensitivity for brain damage results in a clinically useful, high negative predictive value (NPV). Integration of S100B into existing management routines can reduce the need for CT scans or admission by over 30%.

AB - The risk of acute intracranial complications after minor head injury (MHI) is low. Despite this, computed tomography (CT) is generally recommended with clinical observation as a secondary option. Both options have disadvantages. Clinical studies have shown the potential advantages of using the biomarker S100B. The specificity of S100B is low, but a high sensitivity for brain damage results in a clinically useful, high negative predictive value (NPV). Integration of S100B into existing management routines can reduce the need for CT scans or admission by over 30%.

KW - Adult

KW - Biomarkers/blood

KW - Child

KW - Cost Savings

KW - Craniocerebral Trauma/blood

KW - Humans

KW - Nerve Growth Factors/blood

KW - Practice Guidelines as Topic

KW - Predictive Value of Tests

KW - S100 Calcium Binding Protein beta Subunit

KW - S100 Proteins/blood

KW - Sensitivity and Specificity

KW - Tomography, X-Ray Computed/economics

M3 - Tidsskriftartikel

C2 - 19301475

SN - 0041-5782

VL - 171

SP - 978

EP - 981

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 12

ER -

Hjerneskademarkøren S100B kan mindske brugen af computertomografi ved lette hovedtraumer--sekundaerpublikation

Abstract

Emneord

Fingeraftryk

Citationsformater